E-mail a Wiley Online Library Link

Michael A. Liss, John Billimek, Kathryn Osann, Jane Cho, Ross Moskowitz, Adam Kaplan, Richard J. Szabo, Sherrie H. Kaplan, Sheldon Greenfield and Atreya Dash Consideration of comorbidity in risk stratification prior to prostate biopsy Cancer 119

Version of Record online: 25 APR 2013 | DOI: 10.1002/cncr.28044

Organizations are recommending the use of life tables or comorbidity assessment in patients before prostate cancer screening or prostate biopsy to reduce overtreatment; however, they do not provide specific means for comorbidity analysis. In the current study, the authors present the Charlson Comorbidity Index and the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-CaP) as tools to predict acute hospital admission as a surrogate for poor overall health and those patients who should avoid prostate biopsy.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field